ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$76.56

Market cap

$32.1B

P/E Ratio

12.68

Dividend/share

$2.06

EPS

$6.04

Enterprise value

$39.39B

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 8
Relative Valuation: Rel. Valuation: 76
Relative Profitability: Rel. Profitability: 94

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 63% lower than the 5-year quarterly average of 34.5 and 45% lower than the last 4 quarters average of 23.1
Zoetis's EPS has increased by 10% YoY
Zoetis's quick ratio has surged by 85% YoY but it has decreased by 6% QoQ
The debt rose by 37% YoY
ZTS's equity is down by 31% year-on-year and by 5% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: PFE MRK LLY ICCC

Key stats

What are the main financial stats of ZTS

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.46%
1 week
1.32%
1 month
-0.91%
1 year
-48.97%
YTD
-39.15%
QTD
6.54%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$9.51B
Gross profit
$6.82B
Operating income
$3.54B
Net income
$2.64B
Gross margin
71.8%
Net margin
27.8%
The net income has grown by 6% YoY
Zoetis's operating income has increased by 4.7% YoY
The gross profit has grown by 3.9% YoY
ZTS's revenue is up by 2.6% YoY

Price vs fundamentals

How does ZTS's price correlate with its fundamentals

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
ZTS P/E details
P/E
12.68
P/B
10
P/S
3.4
EV/EBIT
11.13
EV/EBITDA
9.79
EV/Sales
4.14
The P/E is 63% lower than the 5-year quarterly average of 34.5 and 45% lower than the last 4 quarters average of 23.1
Zoetis's EPS has increased by 10% YoY
The stock's price to book (P/B) is 40% less than its 5-year quarterly average of 16.7 and 31% less than its last 4 quarters average of 14.4
ZTS's equity is down by 31% year-on-year and by 5% since the previous quarter
ZTS's price to sales (P/S) is 63% lower than its 5-year quarterly average of 9.1 and 47% lower than its last 4 quarters average of 6.4
ZTS's revenue is up by 2.6% YoY

Efficiency

How efficient is Zoetis business performance
The company's return on equity rose by 22% YoY and by 7% QoQ
ZTS's ROIC is down by 11% YoY and by 9% QoQ
ZTS's return on assets is down by 3.3% since the previous quarter
Zoetis's return on sales has increased by 2.2% YoY

Dividends

What is ZTS's dividend history
Dividend details
DPS
$2.06
Dividend yield
2.69%
Payout ratio
34.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 27% greater than its total liabilities
Zoetis's quick ratio has surged by 85% YoY but it has decreased by 6% QoQ
The company's current ratio has surged by 81% YoY
The debt is 186% higher than the equity
Zoetis's debt to equity has surged by 97% YoY and by 6% QoQ
The debt rose by 37% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.